In contrast, the PLAG1 low expression group was enriched in chemokine-mediated signaling pathways and immune-related KEGG pathways, suggesting that PLAG1 downregulation may be associated with enhanced BLCA immune response. Here, PLAG1 is linked to bladder transitional cell carcinoma.